Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L35 pseudogene 3 (RPL35P3)
- Target
- RPL35P3
- Molecular classification
- Other (Pseudogene)
01
Overview
RPL35P3, also known as ribosomal protein L35 pseudogene 3, is a human processed pseudogene with sequence similarity to the functional ribosomal protein L35 gene (RPL35)[1][7]. Pseudogenes like RPL35P3 are noncoding genomic DNA sequences, resulting from duplication or retrotransposition events, and do not produce functional proteins or serve direct cellular functions[1][3][7]. RPL35P3 is not considered a drug target, receptor, enzyme, transporter, or participant in known molecular pathways, nor does it have disease associations or safety profile implications[1][2][7]. Clarification: - RPL35P3 is not a functional gene or protein. - It is incorrectly listed as a therapeutic target, receptor, or protein; it exists only as a nonfunctional pseudogene in the human genome[1][7]. - For structured target information, the relevant functional protein is Ribosomal protein L35 (RPL35), not RPL35P3[5][6].
- Other names
- RPL35_2_728RPL35P3
02
Mechanism of action
None (no therapeutic mechanism due to being a non-functional pseudogene)
03
Biological functions
None (pseudogenes do not encode functional products)
04
Disease associations
Other (Pseudogenes generally have no known direct disease roles, unless specifically shown to act as regulatory RNAs or through other rare mechanisms, which is not the case for RPL35P3)
05
Safety considerations
None (no known safety or therapeutic relevance)
06
Interacting drugs
None (no drugs are known to interact with this pseudogene)
07
Biomarkers
None (not used as a biomarker)
Beyond the preview
Go deeper on Ribosomal protein L35 pseudogene 3 (RPL35P3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L35 pseudogene 3 (RPL35P3).